Cutler Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-200
| Closed | -$27.3K | – | 2838 |
|
|
2023
Q4 | $27K | Buy |
+200
| New | +$24.4K | ﹤0.01% | 1791 |
|
|
2023
Q3 | – | Sell |
-8,198
| Closed | -$1.04M | – | 4017 |
|
|
2023
Q2 | $1.04M | Buy |
8,198
+8,041
| +5,122% | +$1.04M | 0.14% | 165 |
|
|
2023
Q1 | $20K | Sell |
157
-2,116
| -93% | -$277K | ﹤0.01% | 1923 |
|
|
2022
Q4 | $298K | Sell |
2,273
-36
| -2% | -$4.65K | 0.03% | 615 |
|
|
2022
Q3 | $270K | Sell |
2,309
-21,345
| -90% | -$2.65M | 0.02% | 817 |
|
|
2022
Q2 | $2.78M | Buy |
23,654
+16,128
| +214% | +$1.91M | 0.19% | 113 |
|
|
2022
Q1 | $980K | Buy |
+7,526
| New | +$980K | 0.05% | 391 |
|
|
2021
Q4 | – | Sell |
-15,550
| Closed | -$2.41M | – | 5675 |
|
|
2021
Q3 | $2.51M | Buy |
+15,550
| New | +$2.62M | 0.11% | 195 |
|
|
2021
Q1 | – | Sell |
-17,152
| Closed | -$2.72M | – | 5919 |
|
|
2020
Q4 | $2.6M | Sell |
17,152
-7,793
| -31% | -$1.11M | 0.12% | 165 |
|
|
2020
Q3 | $3.38M | Sell |
24,945
-9,138
| -27% | -$1.24M | 0.21% | 92 |
|
|
2020
Q2 | $4.66M | Buy |
34,083
+30,562
| +868% | +$3.9M | 0.31% | 54 |
|
|
2020
Q1 | $379K | Sell |
3,521
-59,980
| -94% | -$6.91M | 0.02% | 657 |
|
|
2019
Q4 | $7.65M | Buy |
63,501
+54,574
| +611% | +$6.09M | 0.47% | 33 |
|
|
2019
Q3 | $888K | Buy |
8,927
+7,227
| +425% | +$757K | 0.08% | 219 |
|
|
2019
Q2 | $185K | Sell |
1,700
-4,182
| -71% | -$445K | 0.02% | 756 |
|
|
2019
Q1 | $657K | Buy |
5,882
+1,282
| +28% | +$141K | 0.07% | 256 |
|
|
2018
Q4 | $443K | Sell |
4,600
-47,510
| -91% | -$5.04M | 0.04% | 364 |
|
|
2018
Q3 | $6.35M | Buy |
+52,110
| New | +$6.14M | 0.44% | 43 |
|
|
2018
Q2 | – | Sell |
-1,000
| Closed | -$107K | – | 4478 |
|
|
2018
Q1 | $106K | Sell |
1,000
-35,828
| -97% | -$3.97M | 0.01% | 1138 |
|
|
2017
Q4 | $3.93M | Sell |
36,828
-11,124
| -23% | -$1.19M | 0.16% | 78 |
|
|
2017
Q3 | $5.33M | Sell |
47,952
-86,358
| -64% | -$9.23M | 0.2% | 71 |
|
|
2017
Q2 | $13.9M | Sell |
134,310
-30,363
| -18% | -$2.99M | 0.51% | 26 |
|
|
2017
Q1 | $16.1M | Buy |
164,673
+87,708
| +114% | +$8.4M | 0.67% | 22 |
|
|
2016
Q4 | $6.81M | Sell |
76,965
-100,899
| -57% | -$9.18M | 0.25% | 64 |
|
|
2016
Q3 | $17.2M | Buy |
177,864
+67,779
| +62% | +$6.45M | 0.77% | 16 |
|
|
2016
Q2 | $9.44M | Sell |
110,085
-45,444
| -29% | -$4.08M | 0.48% | 21 |
|
|
2016
Q1 | $13.5M | Buy |
155,529
+68,238
| +78% | +$6.1M | 0.89% | 8 |
|
|
2015
Q4 | $9.84M | Buy |
+87,291
| New | +$9.47M | 0.55% | 15 |
|
Other funds holding IBB
CB
Cutler Group's IBB Position: Q1 2024 in Review
Cutler Group sold out of iShares Biotechnology ETF (IBB) in Q1 2024, closing a stake of 200 shares — an estimated $27.3K sold.
Cutler Group first reported a position in IBB in Q4 2015 and held it in 28 quarters. The position peaked at $17.2M in Q3 2016. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.
- Cutler Group reported no remaining iShares Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
- Cutler Group sold 200 iShares Biotechnology ETF shares in Q1 2024, an estimated $27.3K.
- Cutler Group first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 28 quarters.
- Cutler Group's iShares Biotechnology ETF position peaked at $17.2M in Q3 2016.
- 899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.